HPV genotype prevalence in low- and high-vaccine coverage, USA populations: Data from real-world cervical cancer screening using the Onclarity HPV assay.

Abstract excerpt

OBJECTIVE: HPV vaccination is an effective strategy for reducing both HPV infection and cervical disease. In the USA, vaccination with the 4-valent HPV vaccine (Merck) has led to a significant reduction in target genotypes HPV16 and 18. However, recent work suggests that vaccination can result in prevalence changes of HPV genotypes not targeted by vaccination (non-vaccine target types). Here we compared genotype...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Early Detection of Cancer
• Share to Human papillomavirus 16